Argyle Capital Management’s Labcorp LH Stock Holding History

Argyle Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$207K	Buy	+776	New	+$210K	0.07%	136
2025 Q4	–	Sell	-776	Closed	-$223K	–	139
2025 Q3	$223K	Hold	776	–	–	0.08%	129
2025 Q2	$204K	Buy	+776	New	+$189K	0.07%	130
2024 Q1	–	Sell	-883	Closed	-$201K	–	119
2023 Q4	$201K	Buy	+883	New	+$185K	0.08%	111
2023 Q3	–	Sell	-1,028	Closed	-$213K	–	123
2023 Q2	$213K	Sell	1,028 -843	-45%	-$164K	0.08%	119
2023 Q1	$369K	Hold	1,871	–	–	0.13%	111
2022 Q4	$378K	Hold	1,871	–	–	0.13%	110
2022 Q3	$329K	Hold	1,871	–	–	0.13%	108
2022 Q2	$377K	Hold	1,871	–	–	0.14%	109
2022 Q1	$424K	Hold	1,871	–	–	0.14%	108
2021 Q4	$505K	Hold	1,871	–	–	0.16%	105
2021 Q3	$452K	Hold	1,871	–	–	0.15%	105
2021 Q2	$443K	Hold	1,871	–	–	0.14%	107
2021 Q1	$410K	Hold	1,871	–	–	0.14%	109
2020 Q4	$327K	Hold	1,871	–	–	0.12%	114
2020 Q3	$303K	Hold	1,871	–	–	0.12%	110
2020 Q2	$267K	Hold	1,871	–	–	0.11%	110
2020 Q1	$203K	Hold	1,871	–	–	0.1%	113
2019 Q4	$272K	Hold	1,871	–	–	0.1%	117
2019 Q3	$270K	Hold	1,871	–	–	0.1%	115
2019 Q2	$278K	Hold	1,871	–	–	0.11%	112
2019 Q1	$246K	Hold	1,871	–	–	0.09%	115
2018 Q4	$203K	Hold	1,871	–	–	0.09%	117
2018 Q3	$279K	Hold	1,871	–	–	0.1%	115
2018 Q2	$289K	Hold	1,871	–	–	0.11%	112
2018 Q1	$260K	Hold	1,871	–	–	0.1%	116
2017 Q4	$256K	Hold	1,871	–	–	0.1%	116
2017 Q3	$243K	Hold	1,871	–	–	0.1%	117
2017 Q2	$248K	Hold	1,871	–	–	0.1%	116
2017 Q1	$231K	Hold	1,871	–	–	0.09%	121
2016 Q4	$206K	Hold	1,871	–	–	0.09%	121
2016 Q3	$221K	Hold	1,871	–	–	0.1%	116
2016 Q2	$209K	Buy	+1,871	New	+$201K	0.09%	115
2016 Q1	–	Sell	-2,183	Closed	-$232K	–	117
2015 Q4	$232K	Sell	2,183 -311	-12%	-$32.1K	0.11%	109
2015 Q3	$232K	Sell	2,494 -1,093	-30%	-$113K	0.11%	107
2015 Q2	$374K	Hold	3,587	–	–	0.17%	98
2015 Q1	$389K	Buy	+3,587	New	+$369K	0.17%	97

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Argyle Capital Management's LH Position: Q1 2026 in Review

Argyle Capital Management opened a new position in Labcorp (LH) in Q1 2026: 776 shares worth $207K. The stake represents 0.07% of the portfolio and ranks #136 among its holdings. This is a return to the name: Argyle Capital Management previously reported a position in LH as recently as Q3 2025.

Argyle Capital Management first reported a position in LH in Q1 2015 and has held it in 37 quarters since. The position peaked at $505K in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Argyle Capital Management held 776 shares of Labcorp worth $207K as of Q1 2026.
Labcorp was a new Argyle Capital Management position in Q1 2026.
Labcorp made up 0.07% of Argyle Capital Management's portfolio in Q1 2026, its #136 holding.
Argyle Capital Management first reported a position in Labcorp in Q1 2015 and has held it in 37 quarters since.
Argyle Capital Management's Labcorp position peaked at $505K in Q4 2021.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Argyle Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.